Live Markets
Saturday, September 12, 2026·George Town, KY·29°·Partly Cloudy
Markets Open · NYSE·Newsletter·Masthead·
VOL. XII · NO. 117Established MMXIV · George Town, Grand CaymanAtlantic Edition · $4.50

The Cayman Journal

Finance · Business · Technology · Caribbean & Global Affairs
Markets · Healthcare

Sunshine Biopharma, Inc. (SBFM)

NCM · Drug Manufacturers - Specialty & Generic

$1.06-0.03 (-2.30%)Quote refreshed

Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires

Market Cap
$4.1M
P/E (TTM)
EPS
$-9.16
Div Yield
52W Range
$1.01–$24.30
Beta
1.32

Company overview

Sunshine Biopharma, Inc. operates as a pharmaceutical company that engages in the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. The company is developing SBFM-PL4, a protease inhibitor for the treatment of SARS coronavirus infections; and K1.1 mRNA, a lipid nano-particle for liver cancer. It also offers Essential 9, an amino acids capsules; Calcium-Vitamin D supplement under the Essential Calcium-Vitamin D brand name; and L-Citrulline and Taurine products. In addition, the company provides various generic prescription drugs for osteoporosis, cardiovascular, antipsychotic, antibacterial, hypertension, anti-inflammatory, allergy, antibiotic, central nervous system, diabetes, urology, antifungal, antimalarial, oncology, gastroenterology, dermatology, smoking cessation, cholelithiasis, anticonvulsant, urology, women's health, acid reflux, and anticonvulsant indications. Sunshine The company is based in Fort Lauderdale, Florida.

Peers in Drug Manufacturers - Specialty & Generic

All in industry →

Recent press releases

Sunshine Biopharma, Inc. has not issued a press release in this window.

SEC filings

All filings →

Sunshine Biopharma, Inc. has not filed an SEC document in this window.

Sunshine Biopharma, Inc. has no reported insider trades in the last 90 days.

Institutional holders

All holders →

No 13F holdings have been reported for Sunshine Biopharma, Inc. in this window.

People at Sunshine Biopharma, Inc.

All people →

Quarterly financials

Full financials →

No quarterly financials have been ingested for Sunshine Biopharma, Inc..